Waseem Raja, Mahrukh and Mohd. Ayaz Bhat*


Introduction: Degenerative pterygium causes visual impairment due to astigmatism and blockade of visual axis. As pterygium cannot be treated medically, surgical excision of pterygium is the only way. Simple excision can be done but it is associated highest recurrence rate. Hence the standard method of preventing the recurrence after pterygium excision is Limbal conjunctival autograft. Adherence of the Auto graft to the excisional site is done by overlaying the auto graft upon the sclera either with sutures or glue routinely. However to address suture and fibrin related complications the concept of Autologous Blood came up. The current study taken up to find out whether autologous blood has become standard technique in treatment of degenerative pterygium. Aim: To assess the efficacy of Autologous blood in the adherence of the limbal conjunctival Autograft. Purpose: To know whether leaving the Autologous blood on the scleral bed can be made as a standard procedure in Pterygium surgery. Materials and Methods: 30 patients with the degenerative pterygium grown beyond the limbus were taken for the study. Patients with bleeding disorders, recurrent pterygium, ocular surface disorders, minimal pterygia and pregnancy were excluded. Pterygium was excised leaving the patient’s own blood on the excised area with minimal cautery and Limbal conjunctival Auto Graft is placed on the bare sclera, and then pad bandage applied. Post operatively eyes were examined whether Limbal conjunctival Autograft is well adhered or not. All the patients were followed for minimum of 6 weeks. Results: All eyes (100%) showed excellent adherence throughout the postoperative period. None of the eyes lost the graft. Conclusion: The autologous blood excellent replacement for sutures and donor fibrin. Autologous blood is simple adjuvant of choice and has become gold standard in Pterygium surgery.

Keywords: Degenerative pterygium Pterygium surgery.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MAY 2022 Issue has been successfully launched on 1 May 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction